Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Express Scripts Tells Caremark Shareholders Vertical Mergers With PBMs Fail

Executive Summary

A merger between pharmacy benefit manager Caremark and pharmacy chain CVS would be plagued by the same problems that vertical mergers involving PBMs have faced in the past, PBM Express Scripts argues in a pamphlet to Caremark shareholders

You may also be interested in...



CVS Suit Against Prasco Illustrates Pricing Leverage From Caremark Merger

A lawsuit by CVS Caremark against generic drug manufacturer Prasco illustrates the potential cross-market leverage that the combined pharmacy/PBM entity is able to wield

CVS Suit Against Prasco Illustrates Pricing Leverage From Caremark Merger

A lawsuit by CVS Caremark against generic drug manufacturer Prasco illustrates the potential cross-market leverage that the combined pharmacy/PBM entity is able to wield

Caremark shareholders approve CVS merger

The PBM's shareholders vote in favor of CVS' roughly $26.7 billion offer during an investor meeting March 16. CVS will have to bridge two pharmacy models after close of the acquisition, which is expected the week of March 19. CVS has positioned the acquisition as an opportunity to transform the way pharmacy services are delivered by blurring the lines between traditional mail order and retail pharmacy services. Express Scripts, as part of a hostile takeover bid, has argued the fundamental differences between the two business models would plague a merger between Caremark and CVS (1"The Pink Sheet" Feb. 26, 2007, p. 17). In response to Express Scripts offer, CVS recently sweetened its offer to include a $7.50 one-time special dividend...

Related Content

UsernamePublicRestriction

Register

PS048069

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel